Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 45 for “"Verteporfin"”.

  1. The effects of verteporfin on non-small cell lung cancer

    … order to improve the prognosis of this disease. Verteporfin, an FDA approved drug, has recently been reported to downregulate a potential core pathway of NSCLC, the Hippo pathway. The pathway consists of a kinase cascade to control the transcriptional coactivators YAP and TAZ. When these …

    iupui Repository record for The effects of verteporfin on non-small cell lung cancer (opens in a new tab)

  2. Φωτοδυναμική θεραπεία ακτινωτού σώματος με verteporfin: πειραματική και κλινική μελέτη

    … ciliary body photodynamic treatment with verteporfin (CBPDT) for use in refractory glaucoma cases. Four experiments with rabbits were first performed, to test safety and efficacy of CBPDT. Since all IOP measurements in rabbits were performed with TonoPen-XL under general anesthesia, the …

    greece Repository record for Φωτοδυναμική θεραπεία ακτινωτού σώματος με verteporfin: πειραματική και κλινική μελέτη (opens in a new tab)

  3. TARGETING CELLULAR METABOLISM BY LEVERAGING THE PHOTOSENSITIZER VERTEPORFIN TO OVERCOME CANCER MULTIDRUG RESISTANCE

    … that photoactivation of the photosensitizer, verteporfin (VP), can directly cause P-gp aggregation due to cross-linking of the protein. Photoactivation of VP resulting in indirect P-gp inhibition, such as by depleting ATP levels, has been understudied. In this context, this thesis aims to …

    maryland Repository record for TARGETING CELLULAR METABOLISM BY LEVERAGING THE PHOTOSENSITIZER VERTEPORFIN TO OVERCOME CANCER MULTIDRUG RESISTANCE (opens in a new tab)

  4. Gezielte photodynamische Therapie mit in kationischen Liposomen enkapsuliertem Verteporfin im Laser-CNV-Mausmodell

    … ist die PDT mit dem <br>Photosensibilisator Verteporfin (Visudyne®), welche auf einer phototoxischen Thrombose der CNV-Membranen basiert. <br>Kationische Liposomen sind eine Modifikation konventioneller Liposomen, die aufgrund ihrer positiven Oberflächenladung eine starke Affinität für …

    freiburg-diss Repository record for Gezielte photodynamische Therapie mit in kationischen Liposomen enkapsuliertem Verteporfin im Laser-CNV-Mausmodell (opens in a new tab)

  5. Characterization of verteporfin as an inhibitor of autophagosome formation and its therapeutic potential in cancer

    … novel inhibitors of autophagosome accumulation. Verteporfin, a benzoporphyrin derivative used in photodynamic therapy, was the only active compound identified. As a photosensitizer, verteporfin generates large amounts of singlet oxygen upon light irradiation, which elicits a cell-death response. …

    ubc Repository record for Characterization of verteporfin as an inhibitor of autophagosome formation and its therapeutic potential in cancer (opens in a new tab) Download PDF for Characterization of verteporfin as an inhibitor of autophagosome formation and its therapeutic potential in cancer (opens in a new tab)

  6. Mass spectrometry and laser photodissociation spectroscopy of gas-phase metalloporphyrin complexes, metalloporphyrin radicals, and Verteporfin

    … experiments presented in this thesis focuses on verteporfin (trade name Visudyne), a benzoporphyrin derivative photosensitizer used in photodynamic therapy of the treatment of the wet form of macular degeneration. In this work, the first direct study of its photoproducts and photofragmentation …

    whiterose Download PDF for Mass spectrometry and laser photodissociation spectroscopy of gas-phase metalloporphyrin complexes, metalloporphyrin radicals, and Verteporfin (opens in a new tab)

  7. PREPARATION OF A NANOSUSPENSION OF THE PHOTOSENSITIZER VERTEPORFIN FOR PHOTODYNAMIC AND LIGHT-INDEPENDENT THERAPY IN GLIOBLASTOMA

    Photodynamic therapy (PDT) using verteporfin (VP) has treated ocular disease for over 20 years, but recent interest in VP’s light-independent properties has reignited interest in the drug, particularly in glioblastoma (GBM) (NCT04590664). Separate efforts to apply PDT to GBM using 5-aminolevulinic …

    maryland Repository record for PREPARATION OF A NANOSUSPENSION OF THE PHOTOSENSITIZER VERTEPORFIN FOR PHOTODYNAMIC AND LIGHT-INDEPENDENT THERAPY IN GLIOBLASTOMA (opens in a new tab)

  8. An Exploration of the Role of Fibronectin in the Anti-Metastatic Properties of Verteporfin in Osteosarcoma

    … for additional therapies. Previous work with verteporfin (VP) highlighted its ability to inhibit growth of metastatic K7M2 OS cells alongside an increase in tissue stiffness. Fibronectin (FN1) was investigated as a mediator of this effect via analysis of K7M2 cells following VP treatment. This …

    guelph Repository record for An Exploration of the Role of Fibronectin in the Anti-Metastatic Properties of Verteporfin in Osteosarcoma (opens in a new tab) Embargoed until 2026-12-16

  9. Funktionelle Ergebnisse und Nebenwirkungen der Photodynamischen Therapie mit Verteporfin bei der Behandlung des Hämangioms der Aderhaut

    … mittels Photodynamischer Therapie mit Verteporfin (Visudyne®, Novartis, Bülach, CH) zeigte in unserer Arbeit insgesamt gute Ergebnisse im Hinblick auf die Reduktion der Tumorprominenz, den Visusverlauf und die Rückbildung der subretinalen Flüssigkeit sowie der Exsudation. Nach einer …

    fu-berlin Repository record for Funktionelle Ergebnisse und Nebenwirkungen der Photodynamischen Therapie mit Verteporfin bei der Behandlung des Hämangioms der Aderhaut (opens in a new tab)

  10. Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin

    … benzoporphyrin derivative monoacid ring A (BPD) verteporfin which absorbs strongly at 690 nm, on murine skin allograft rejection was tested using a unique approach. Skin sections (C57BL/6)were exposed in vitro to varying doses of BPD (0.125 - 1.0 μg/mL) and 10 J/cm² light at a wavelength of 690 …

    ubc Repository record for Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin (opens in a new tab) Download PDF for Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin (opens in a new tab)

  11. A Pilot Investigation on Immunogenic Cell Death Induction by Verteporfin-Photodynamic Therapy in Metastatic Murine Osteosarcoma Cells

    … highlighting the need for alternative therapies. Verteporfin (VP)-photodynamic therapy (PDT) shows promise due to VP's ability to inhibit the transcriptional co-activator yes-associated protein (YAP) and affect the tumour microenvironment. I hypothesized that VP modulates the immune tumour …

    guelph Repository record for A Pilot Investigation on Immunogenic Cell Death Induction by Verteporfin-Photodynamic Therapy in Metastatic Murine Osteosarcoma Cells (opens in a new tab)

  12. Local photodynamic therapy for equine squamous cell carcinoma in a murine model

    … groups received intra-tumoral injection of verteporfin at a dose of 0.01, 0.1 or 1.0 mg/cm3 dissolved in DMSO. Controls received only DMSO or no injectate. In study 2 (solvent effect), two treatment groups received verteporfin (0.1mg/cm3) dissolved in 5% dextrose solution (D5W) or DMSO. …

    missouri Repository record for Local photodynamic therapy for equine squamous cell carcinoma in a murine model (opens in a new tab)

  13. Hypoxia in gliomas: a pathogenic driver and therapeutic opportunity

    … gliomas and thus the effect of YAP inhibitor, verteporfin was investigated. Treatment of primary and immortalised glioma cell lines with verteporfin resulted in cell death but strikingly only under hypoxic conditions (1% O2). This investigation discovered that cell death occurs through a …

    birmingham Download PDF for Hypoxia in gliomas: a pathogenic driver and therapeutic opportunity (opens in a new tab)

  14. Non-invasive imaging of lymphatic remodeling in response to injury through photodynamic therapy

    … system. Recently, it has been shown that verteporfin, a photosensitive drug widely used for photodynamic therapy (PDT) to ablate the blood vessels, provides a similar effect on lymphatic vessels. Here, we seek to administer verteporfin and perform PDT of collecting lymphatics in the mouse …

    gatech Repository record for Non-invasive imaging of lymphatic remodeling in response to injury through photodynamic therapy (opens in a new tab)

  15. Connecting the Dots: A Multi-Approach Investigation to Identify New Molecular Targets for Canine Osteosarcoma

    … study explored the use of the YAP inhibitor, verteporfin, for the treatment of advanced disease and characterized its impact on the lung microenvironment throughout metastasis development. This study found that the lung’s innate immune cells increase throughout metastatic progression, while …

    guelph Repository record for Connecting the Dots: A Multi-Approach Investigation to Identify New Molecular Targets for Canine Osteosarcoma (opens in a new tab)

  16. Multi-Functional Polymer Vesicles: Applications in Chemotherapy and Photodynamic Therapy

    … an existing photosensitizer formulation called verteporfin that is currently used in the clinic for age-related macular degeneration (AMD). The polymersome formulation outperformed verteporfin both at the in vitro and in vivo level. Additionally, we investigated the photorupture of giant …

    penn Repository record for Multi-Functional Polymer Vesicles: Applications in Chemotherapy and Photodynamic Therapy (opens in a new tab)

Page 1 of 3